Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$259.69+3.34 (+1.30%)
Close on Nov 18, 2026Market cap $28.57BP/E 25.9Yield –
Quest Diagnostics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Quest Diagnostics's operating income for the twelve months ending Sep 30, 2026 was $1.72B, up 12.5% year over year. For fiscal 2025 it was $1.56B, up 15.6% from the year before. Over ten years it grew 1.1% a year on average. The highest annual figure on record is $2.38B in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.56B | +15.6% |
| FY2024 | Dec 31, 2024 | $1.35B | +6.7% |
| FY2023 | Dec 31, 2023 | $1.26B | -11.6% |
| FY2022 | Dec 31, 2022 | $1.43B | -40.0% |
| FY2021 | Dec 31, 2021 | $2.38B | +20.8% |
| FY2020 | Dec 31, 2020 | $1.97B | +60.1% |
| FY2019 | Dec 31, 2019 | $1.23B | +11.8% |
| FY2018 | Dec 31, 2018 | $1.10B | -5.5% |
| FY2017 | Dec 31, 2017 | $1.17B | -8.8% |
| FY2016 | Dec 31, 2016 | $1.28B | -8.7% |
| FY2015 | Dec 31, 2015 | $1.40B | +42.3% |
| FY2014 | Dec 31, 2014 | $983.00M | -33.4% |
| FY2013 | Dec 31, 2013 | $1.48B | +22.8% |
| FY2012 | Dec 31, 2012 | $1.20B | +21.7% |
| FY2011 | Dec 31, 2011 | $987.00M | -23.1% |
| FY2010 | Dec 31, 2010 | $1.28B | -5.6% |
| FY2009 | Dec 31, 2009 | $1.36B | +11.2% |
| FY2008 | Dec 31, 2008 | $1.22B | +12.0% |
| FY2007 | Dec 31, 2007 | $1.09B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $479.00M | +24.1% |
| Q2 FY2026 | Jun 30, 2026 | $459.00M | +4.8% |
| Q1 FY2026 | Mar 31, 2026 | $399.00M | +15.3% |
| Q4 FY2025 | Dec 31, 2025 | $386.00M | +6.9% |
| Q3 FY2025 | Sep 30, 2025 | $386.00M | +17.0% |
| Q2 FY2025 | Jun 30, 2025 | $438.00M | +23.4% |
| Q1 FY2025 | Mar 31, 2025 | $346.00M | +15.3% |
| Q4 FY2024 | Dec 31, 2024 | $361.00M | +35.2% |
| Q3 FY2024 | Sep 30, 2024 | $330.00M | -3.5% |
| Q2 FY2024 | Jun 30, 2024 | $355.00M | +2.0% |
| Q1 FY2024 | Mar 31, 2024 | $300.00M | -1.6% |
| Q4 FY2023 | Dec 31, 2023 | $267.00M | +97.8% |
| Q3 FY2023 | Sep 30, 2023 | $342.00M | -12.8% |
| Q2 FY2023 | Jun 30, 2023 | $348.00M | -10.3% |
| Q1 FY2023 | Mar 31, 2023 | $305.00M | -40.5% |
| Q4 FY2022 | Dec 31, 2022 | $135.00M | -74.8% |
| Q3 FY2022 | Sep 30, 2022 | $392.00M | -39.9% |
| Q2 FY2022 | Jun 30, 2022 | $388.00M | -27.2% |
| Q1 FY2022 | Mar 31, 2022 | $513.00M | -22.3% |
| Q4 FY2021 | Dec 31, 2021 | $536.00M | -32.6% |
| Q3 FY2021 | Sep 30, 2021 | $652.00M | -9.2% |
| Q2 FY2021 | Jun 30, 2021 | $533.00M | +88.3% |
| Q1 FY2021 | Mar 31, 2021 | $660.00M | +277.1% |
| Q4 FY2020 | Dec 31, 2020 | $795.00M | +119.0% |
| Q3 FY2020 | Sep 30, 2020 | $718.00M | +129.4% |
| Q2 FY2020 | Jun 30, 2020 | $283.00M | -7.8% |
| Q1 FY2020 | Mar 31, 2020 | $175.00M | -29.4% |
| Q4 FY2019 | Dec 31, 2019 | $363.00M | +65.0% |
| Q3 FY2019 | Sep 30, 2019 | $313.00M | +3.0% |
| Q2 FY2019 | Jun 30, 2019 | $307.00M | +0.7% |
| Q1 FY2019 | Mar 31, 2019 | $248.00M | -8.8% |
| Q4 FY2018 | Dec 31, 2018 | $220.00M | -18.2% |
| Q3 FY2018 | Sep 30, 2018 | $304.00M | +2.0% |
| Q2 FY2018 | Jun 30, 2018 | $305.00M | -4.4% |
| Q1 FY2018 | Mar 31, 2018 | $272.00M | -2.5% |
| Q4 FY2017 | Dec 31, 2017 | $269.00M | -2.5% |
| Q3 FY2017 | Sep 30, 2017 | $298.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $319.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $279.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $276.00M | – |
See a number that looks wrong?